FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
June 20, 2023 -- Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Children | Diabetes | Diabetes Type 2 | Diets | Drugs & Pharmacology | Empagliflozin | Endocrinology | Food and Drug Administration (FDA) | Fortamet | Jardiance | Metformin | Nutrition | Pediatrics | Sports Medicine | Sugar